ALLO(Allogene Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-10-21 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 36,342 | $1.34 |
| 2026-08-21 | Douglas Earl Martin | SVP, General Counsel | 公开市场卖出 | 29,697 | $2.12 |
| 2026-04-21 | Yoshiyama Annie | SVP, Finance | 公开市场卖出 | 9,586 | $2.31 |
| 2026-03-31 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 公开市场卖出 | 2,867 | $2.50 |
| 2026-03-16 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 公开市场卖出 | 4,835 | $2.47 |
| 2026-03-16 | Chang David D | President and CEO | 公开市场卖出 | 47,763 | $2.47 |
| 2026-03-02 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 公开市场卖出 | 7,132 | $2.60 |
| 2026-02-02 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 公开市场卖出 | 7,549 | $1.73 |
| 2026-02-02 | Chang David D | President and CEO | 公开市场卖出 | 95,269 | $1.80 |
| 2026-02-02 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 24,001 | $1.76 |
| 2026-02-02 | Yoshiyama Annie | SVP, Finance | 公开市场卖出 | 4,167 | $1.72 |
| 2026-02-02 | Roberts Zachary | EVP of R&D | 公开市场卖出 | 35,700 | $1.77 |
| 2026-02-02 | Douglas Earl Martin | SVP, General Counsel | 公开市场卖出 | 22,900 | $1.76 |
| 2026-01-21 | Roberts Zachary | EVP of R&D | 公开市场卖出 | 26,269 | $1.56 |
| 2025-11-17 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 公开市场卖出 | 786 | $1.22 |
| 2025-10-21 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 36,744 | $1.26 |
| 2025-06-10 | MESSEMER DEBORAH M. | 董事 | 公开市场卖出 | 36,885 | $1.42 |
| 2025-04-21 | Yoshiyama Annie | SVP, Finance | 公开市场卖出 | 9,601 | $1.41 |
| 2025-03-14 | Chang David D | President and CEO | 公开市场卖出 | 46,668 | $1.96 |
| 2025-03-14 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 公开市场卖出 | 5,488 | $1.98 |